We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IPA market cap is 10.37M. The company's latest EPS is CAD -0.9955 and P/E is -0.38.
| Quarter End | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 5.69M | 6.15M | 6.22M | 6.46M | 5.26M |
| Operating Income | -4.18M | -3.03M | -3.34M | -18.58M | -4.77M |
| Net Income | -3.57M | -2.63M | -2.94M | -18.05M | -4M |
| Year End April 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 14.06M | 17.91M | 19.37M | 20.67M | 24.52M |
| Operating Income | -2.33M | -4.87M | -12.52M | -28.55M | -29.13M |
| Net Income | -4.95M | -7.34M | -16.71M | -26.56M | -27.18M |
| Quarter End | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 76.58M | 75.61M | 78.69M | 59.99M | 59.3M |
| Total Liabilities | 22.74M | 23.58M | 28.87M | 26.07M | 26.45M |
| Total Equity | 53.85M | 52.03M | 49.82M | 33.92M | 32.85M |
| Year End April 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 27.26M | 66.96M | 93.49M | 77.81M | 59.99M |
| Total Liabilities | 12.18M | 10.04M | 18.21M | 20.01M | 26.07M |
| Total Equity | 15.09M | 56.92M | 75.29M | 57.8M | 33.92M |
| Quarter End | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -702k | -937k | -1.6M | -4.25M | -1.82M |
| Investing | -197k | -509k | -452k | -1.56M | -263k |
| Financing | -405k | -715k | -102k | 1.02M | 2.7M |
| Year End April 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -1.39M | -600k | -9.92M | -19.83M | -4.25M |
| Investing | -1.58M | -2.46M | -5.21M | -1.97M | -1.56M |
| Financing | 174k | 43.38M | 2.88M | -621k | 1.02M |
| Market Cap | 10.37M |
| Price to Earnings Ratio | -0.38 |
| Price to Sales Ratio | 0.42 |
| Price to Cash Ratio | 3 |
| Price to Book Ratio | 0.31 |
| Dividend Yield | - |
| Shares Outstanding | 27.3M |
| Average Volume (1 week) | 369.79k |
| Average Volume (1 Month) | 271.22k |
| 52 Week Change | -68.07% |
| 52 Week High | 2.60 |
| 52 Week Low | 0.3248 |
| Spread (Intraday) | 0.05 (12.38%) |
| Company Name | ImmunoPrecise Antibodies Ltd |
| Address |
3204 - 4464 markham street victoria, british columbia V8Z 7X8 |
| Website | https://www.immunoprecise.com |
| Industry | miscellaneous metal ores,nec (1099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
